Insider Transactions in Q1 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
7,603
-78.71%
|
$296,517
$39.36 P/Share
|
|
Mar 03
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,779
-0.7%
|
$67,602
$38.82 P/Share
|
|
Mar 03
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,603
+1.41%
|
-
|
|
Mar 03
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
12,127
-4.4%
|
$460,826
$38.69 P/Share
|
|
Mar 02
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
9,475
-3.33%
|
$360,050
$38.84 P/Share
|
|
Mar 02
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
1,360
-12.34%
|
$51,680
$38.9 P/Share
|
|
Feb 28
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-0.69%
|
$75,544
$38.78 P/Share
|
|
Feb 28
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,481
+1.54%
|
-
|
|
Feb 28
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-0.25%
|
$18,202
$38.78 P/Share
|
|
Feb 28
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,629
+0.83%
|
-
|
|
Feb 28
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
419
-1.97%
|
$15,922
$38.78 P/Share
|
|
Feb 28
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+6.3%
|
-
|
|
Feb 28
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.68%
|
$22,648
$38.78 P/Share
|
|
Feb 28
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,528
+4.14%
|
-
|
|
Feb 28
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-1.17%
|
$41,192
$38.78 P/Share
|
|
Feb 28
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+2.56%
|
-
|
|
Feb 28
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,130
-0.38%
|
$308,940
$38.78 P/Share
|
|
Feb 28
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,330
+0.86%
|
-
|
|
Feb 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-0.66%
|
$35,302
$38.78 P/Share
|
|
Feb 28
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,037
+1.43%
|
-
|
|
Feb 28
2021
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
235
-0.63%
|
$8,930
$38.78 P/Share
|
|
Feb 28
2021
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
815
+2.14%
|
-
|
|
Feb 28
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.91%
|
$11,362
$38.78 P/Share
|
|
Feb 28
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,018
+3.01%
|
-
|
|
Feb 28
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-0.23%
|
$21,432
$38.78 P/Share
|
|
Feb 28
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
1,629
+0.66%
|
-
|
|
Feb 28
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
1,084
-8.96%
|
$41,192
$38.78 P/Share
|
|
Feb 28
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
2,444
+16.8%
|
-
|
|
Feb 28
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-1.79%
|
$11,362
$38.78 P/Share
|
|
Feb 28
2021
|
Meghan Scanlon SVP,Pres,Urology Pelvic Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,018
+5.75%
|
-
|
|
Feb 28
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
704
-4.94%
|
$26,752
$38.78 P/Share
|
|
Feb 28
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,426
+9.1%
|
-
|
|
Feb 28
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-0.74%
|
$14,212
$38.78 P/Share
|
|
Feb 28
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,222
+2.35%
|
-
|
|
Feb 28
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.91%
|
$37,734
$38.78 P/Share
|
|
Feb 28
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,833
+1.66%
|
-
|
|
Feb 26
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Bona fide gift
|
Direct |
2,700
-7.38%
|
-
|
|
Feb 23
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
24,846
-8.09%
|
$968,994
$39.23 P/Share
|
|
Feb 23
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,846
+7.48%
|
$173,922
$7.16 P/Share
|
|
Feb 23
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,836
-22.7%
|
$110,604
$39.2 P/Share
|
|
Feb 22
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,570
-0.9%
|
$100,230
$39.2 P/Share
|
|
Feb 22
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,794
+1.99%
|
-
|
|
Feb 22
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
396
-1.07%
|
$15,444
$39.2 P/Share
|
|
Feb 22
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,014
+2.67%
|
-
|
|
Feb 22
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-0.35%
|
$26,559
$39.2 P/Share
|
|
Feb 22
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,318
+1.18%
|
-
|
|
Feb 22
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-1.4%
|
$50,115
$39.2 P/Share
|
|
Feb 22
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,897
+3.06%
|
-
|
|
Feb 22
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,279
-0.49%
|
$400,881
$39.2 P/Share
|
|
Feb 22
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,175
+1.08%
|
-
|